Insights into significant pathways and gene interaction networks underlying breast cancer cell line MCF-7 treated with 17β-estradiol (E2).

OBJECTIVE Estrogens are known to regulate the proliferation of breast cancer cells and to alter their cytoarchitectural and phenotypic properties, but the gene networks and pathways by which estrogenic hormones regulate these events are only partially understood. METHODS We used global gene expression profiling by Affymetrix GeneChip microarray analysis, with KEGG pathway enrichment, PPI network construction, module analysis and text mining methods to identify patterns and time courses of genes that are either stimulated or inhibited by estradiol (E2) in estrogen receptor (ER)-positive MCF-7 human breast cancer cells. RESULTS Of the genes queried on the Affymetrix Human Genome U133 plus 2.0 microarray, we identified 628 (12h), 852 (24h) and 880 (48 h) differentially expressed genes (DEGs) that showed a robust pattern of regulation by E2. From pathway enrichment analysis, we found out the changes of metabolic pathways of E2 treated samples at each time point. At 12h time point, the changes of metabolic pathways were mainly focused on pathways in cancer, focal adhesion, and chemokine signaling pathway. At 24h time point, the changes were mainly enriched in neuroactive ligand-receptor interaction, cytokine-cytokine receptor interaction and calcium signaling pathway. At 48 h time point, the significant pathways were pathways in cancer, regulation of actin cytoskeleton, cell adhesion molecules (CAMs), axon guidance and ErbB signaling pathway. Of interest, our PPI network analysis and module analysis found that E2 treatment induced enhancement of PRSS23 at the three time points and PRSS23 was in the central position of each module. Text mining results showed that the important genes of DEGs have relationship with signal pathways, such as ERbB pathway (AREG), Wnt pathway (NDP), MAPK pathway (NTRK3, TH), IP3 pathway (TRA@) and some transcript factors (TCF4, MAF). CONCLUSIONS Our studies highlight the diverse gene networks and metabolic and cell regulatory pathways through which E2 operates to achieve its widespread effects on breast cancer cells.

[1]  S Sommer,et al.  Estrogen Receptor and Breast Cancer , 2001, Cancer Drug Discovery and Development.

[2]  Brad T. Sherman,et al.  The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists , 2007, Genome Biology.

[3]  Haiyuan Yu,et al.  Detecting overlapping protein complexes in protein-protein interaction networks , 2012, Nature Methods.

[4]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[5]  D. Ingber,et al.  Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion , 2010, The Journal of experimental medicine.

[6]  D. Yamazaki,et al.  Regulation of cancer cell motility through actin reorganization , 2005, Cancer science.

[7]  H. Ditzel,et al.  Gene Expression Signatures That Predict Outcome of Tamoxifen-Treated Estrogen Receptor-Positive, High-Risk, Primary Breast Cancer Patients: A DBCG Study , 2013, PloS one.

[8]  J. Baldwin.  The probable arrangement of the helices in G protein‐coupled receptors. , 1993, The EMBO journal.

[9]  F. Itoh,et al.  Role of Bile Acids in Carcinogenesis of Gastrointestinal Tract , 2012 .

[10]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[12]  M. Neumaier,et al.  Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[14]  Kuan-Ting Lin,et al.  Serine Protease PRSS23 Is Upregulated by Estrogen Receptor α and Associated with Proliferation of Breast Cancer Cells , 2012, PloS one.

[15]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[16]  J. Condeelis,et al.  Regulation of the actin cytoskeleton in cancer cell migration and invasion. , 2007, Biochimica et biophysica acta.

[17]  Li-Ming Zhou,et al.  Calycosin stimulates proliferation of estrogen receptor-positive human breast cancer cells through downregulation of Bax gene expression and upregulation of Bcl-2 gene expression at low concentrations. , 2011, JPEN. Journal of parenteral and enteral nutrition.

[18]  F. Bertucci,et al.  Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets , 2013, Clinical Cancer Research.

[19]  Kazuo Umezawa,et al.  ErbB receptor tyrosine kinase/NF-κB signaling controls mammosphere formation in human breast cancer , 2012, Proceedings of the National Academy of Sciences.

[20]  Margaret Gardiner-Garden,et al.  Overexpression of the Cell Adhesion Molecules DDR1, Claudin 3, and Ep-CAM in Metaplastic Ovarian Epithelium and Ovarian Cancer , 2004, Clinical Cancer Research.

[21]  K. Shilo,et al.  Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB2 in Modulating Breast Cancer Growth and Invasion , 2011, PloS one.

[22]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[23]  Yuqiu Jiang,et al.  Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarrays , 2002, Oncogene.

[24]  Marcel Garcia,et al.  Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. , 2004, Critical reviews in oncology/hematology.

[25]  S. Wessler,et al.  Differential gene expression in ERα-positive and ERα-negative breast cancer cells upon leptin stimulation , 2013, Endocrine.

[26]  R. Prekeris,et al.  Rab11-FIP3 is a Rab11-binding protein that regulates breast cancer cell motility by modulating the actin cytoskeleton. , 2009, European journal of cell biology.

[27]  S. Ethier,et al.  Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. , 2001, Cancer research.

[28]  J. Ochieng,et al.  Annexin A6 contributes to the invasiveness of breast carcinoma cells by influencing the organization and localization of functional focal adhesions. , 2011, Experimental cell research.

[29]  Maria Victoria Schneider,et al.  MINT: a Molecular INTeraction database. , 2002, FEBS letters.

[30]  S. Fuqua,et al.  Estrogen Receptor Mutations and Changes in Downstream Gene Expression and Signaling , 2010, Clinical Cancer Research.

[31]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[32]  Jihe Zhao,et al.  The Role of chemokine receptor CXCR4 in breast cancer metastasis. , 2013, American journal of cancer research.

[33]  E. Lobenhofer,et al.  Regulation of DNA replication fork genes by 17beta-estradiol. , 2002, Molecular endocrinology.

[34]  Krzysztof Fujarewicz,et al.  Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. , 2005, Cancer research.

[35]  De-shuang Huang,et al.  An Algorithm for Finding Functional Modules and Protein Complexes in Protein-Protein Interaction Networks , 2008, Journal of biomedicine & biotechnology.

[36]  W. Chan,et al.  U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3 , 2005, Cancer Cell International.

[37]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[38]  D. Dye,et al.  The Role of Immunoglobulin Superfamily Cell Adhesion Molecules in Cancer Metastasis , 2012, International journal of cell biology.

[39]  C. Dubay,et al.  The Identification of Novel Ovarian Proteases Through the Use of Genomic and Bioinformatic Methodologies1 , 2006, Biology of reproduction.

[40]  S. Sheen-Chen,et al.  An evaluation of focal adhesion kinase in breast cancer by tissue microarrays. , 2013, Anticancer research.

[41]  Patrick Pauwels,et al.  Array-Based DNA Methylation Profiling for Breast Cancer Subtype Discrimination , 2010, PloS one.

[42]  Kara Dolinski,et al.  The BioGRID Interaction Database: 2011 update , 2010, Nucleic Acids Res..

[43]  G. O'Neill.  Scared stiff , 2011, Bioarchitecture.

[44]  Vidhya Jagannathan,et al.  Meta-analysis of estrogen response in MCF-7 distinguishes early target genes involved in signaling and cell proliferation from later target genes involved in cell cycle and DNA repair , 2011, BMC Systems Biology.

[45]  D. Kalaitzidis,et al.  Transcription factor cross-talk: the estrogen receptor and NF-κB , 2005, Trends in Endocrinology & Metabolism.

[46]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[47]  F. Stossi,et al.  Whole-Genome Cartography of Estrogen Receptor α Binding Sites , 2007, PLoS genetics.

[48]  J. Gustafsson,et al.  Estrogen receptor action. , 2002, Critical reviews in eukaryotic gene expression.

[49]  Tommaso Simoncini,et al.  Extra-Nuclear Signaling of Progesterone Receptor to Breast Cancer Cell Movement and Invasion through the Actin Cytoskeleton , 2008, PloS one.

[50]  S. Kato.  Estrogen receptor-mediated cross-talk with growth factor signaling pathways , 2001, Breast cancer.

[51]  Barry Komm,et al.  Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. , 2003, Endocrinology.

[52]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[53]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[54]  Cory C. Funk,et al.  The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells. , 2011, Molecular endocrinology.

[55]  V. Craig Jordan,et al.  International Union of Pharmacology. LXIV. Estrogen Receptors , 2006, Pharmacological Reviews.

[56]  Jorge S Reis-Filho,et al.  Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction , 2011, Breast Cancer Research.

[57]  J. Mendelsohn,et al.  Heregulin Regulates Cytoskeletal Reorganization and Cell Migration through the p21-activated Kinase-1 via Phosphatidylinositol-3 Kinase* , 1998, The Journal of Biological Chemistry.

[58]  Stefan Offermanns,et al.  ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis. , 2012, The Journal of clinical investigation.

[59]  E. Lobenhofer,et al.  Regulation of DNA Replication Fork Genes by 17β-Estradiol , 2002 .